Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Adult |
Dose: Tablet – 1600 mg of Favipiravir Frequency: twice daily Duration: Day 1 |
|
Age: Adult |
Dose: Tablet – 600 mg of Favipiravir Frequency: twice daily Duration: Day 2 to Day 5 Note: The total treatment duration should be 5 days. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Tablet – No approved pediatric dosage available Note: No approved pediatric dosage available |
Administration
- Take with or without food
- Complete full course as prescribed
Side Effect
- This drug is only approved as an experimental drug and still a lot of studies is needed about it's efficacy and also toxic reactions and other side effects
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No specific drug interactions mentioned
|
This drug is only approved as an experimental drug and still a lot of studies is needed about its efficacy and also toxic reactions and drug interactions
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Experimental Drug - Contraindications Not Fully Known
|
Unknown adverse effects
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.